RX.png

Buprenorphine Prescriber Training

APA offers a number of training approaches for medication assisted treatment.

The 8-hour training activities below meet the Federal training requirement of the Drug Addiction Treatment Act of 2000 (DATA 2000). Completion will allow qualified physicians to apply for a waiver to their Drug Enforcement Administration (DEA) license, and thus to provide office-based treatment of opioid use disorder with buprenorphine. Physicians wishing to become waiver eligible can complete any one of the activities below.

Educational Offerings

Learning Method Registration Complete Quiz, Evaluation, and Credit Claim
book-2.png
Book-based Learning – Office-Based Buprenorphine Treatment of Opioid Use Disorder, Second Edition
Purchase Claim Credit
monitor.png
Online Training
Purchase Claim Credit
Podium
Live Learning at the 2019 APA Annual Meeting
Registration Closed Claim Credit

Instructions for Applying for a Buprenorphine Waiver

Once you have completed one of the above trainings and claimed your CME credit, APA will report your completion to SAMHSA. To claim your Buprenorphine Waiver, you must go to SAMSHA's "Buprenorphine Waiver Notification" website no sooner than 15 days from now. APA sends SAMSHA notifications of waiver training completion biweekly, and your information will be included in our next transmission.

Medication-Assisted Treatment (MAT) Booster Activity

Using a question-based format, participants receive one multiple-choice question, by email, every other day. The activity consists of 25 questions over 60 days. Questions address the diagnosis, treatment, and longitudinal care of patients with Opioid Use Disorders.

View More

Already a MAT Prescriber?

Consider becoming a technical assistance consultant in your community.

Learn More

Model Curriculum in Substance Use Disorders

APA's council on Addiction Psychiatry and Council on Medical Education has formed a workgroup for the purpose of identifying, evaluating and developing a curriculum on substance use disorders. The National Institute on Drug Abuse (NIDA) and APA will develop educational activities that will enable learners to manage psychoactive substance intoxication associated withdrawal and evidence-based psychotherapy and psychosocial interventions that include cognitive behavioral therapy and motivational interviewing.

View More